http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106397455-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-22 |
filingDate | 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106397455-B |
titleOfInvention | A kind of anti-infectives Ceftibuten crystalline compounds and combinations thereof |
abstract | The invention belongs to pharmaceutical technology field, a kind of anti-infectives Ceftibuten crystalline compounds and combinations thereof are disclosed.Shown in the structural formula such as formula (I) of the Ceftibuten crystalline compounds, which is measured with powder x-ray diffraction measuring method, as shown in Figure 1 with the X-ray powder diffraction pattern that the 2 θ ± 0.2 ° angles of diffraction indicate.The crystalline compounds purity is high, and polymer content is low, and stability is good, and not easy to moisture absorption, good fluidity, substantially increases its dissolubility.Low using capsule dissolubility height, impurity content made of the crystalline compounds, stability is good. |
priorityDate | 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.